James F. Polewaczyk - 14 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Issuer symbol
IDXX
Transactions as of
14 Feb 2024
Net transactions value
-$156,396
Form type
4
Filing time
16 Feb 2024, 17:57:31 UTC
Previous filing
08 Dec 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +126 +1.3% $0.000000 10,189 14 Feb 2024 Direct F1
transaction IDXX Common Stock Options Exercise $0 +216 +2.1% $0.000000 10,405 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +161 +1.5% $0.000000 10,566 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +204 +1.9% $0.000000 10,770 14 Feb 2024 Direct
transaction IDXX Common Stock Options Exercise $0 +220 +2% $0.000000 10,990 14 Feb 2024 Direct
transaction IDXX Common Stock Tax liability $156,396 -279 -2.5% $560.56 10,711 14 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise $0 -126 -100% $0.000000* 0 14 Feb 2024 Common Stock 126 Direct F2
transaction IDXX Restricted Stock Unit Options Exercise $0 -216 -100% $0.000000* 0 14 Feb 2024 Common Stock 216 Direct F3
transaction IDXX Restricted Stock Unit Options Exercise $0 -161 -50% $0.000000 160 14 Feb 2024 Common Stock 161 Direct F4
transaction IDXX Restricted Stock Unit Options Exercise $0 -204 -33% $0.000000 408 14 Feb 2024 Common Stock 204 Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -220 -25% $0.000000 660 14 Feb 2024 Common Stock 220 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023.
F2 Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.